Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DreamHug Medical vs Hims & Hers

DreamHug Medical
Graded #393

Lower grade

vs+23.4
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 57.6/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +26
56
82
Dose & formulationHims & Hers +14
64
78
Clinical oversightHims & Hers +22
60
82
Labs & monitoringHims & Hers +30
50
80
FulfillmentHims & Hers +17
67
84
Contract termsHims & Hers +39
41
80
DreamHug Medical · left barHims & Hers · right bar

The numbers

MetricDreamHug MedicalHims & Hers
WeighScore57.6/10081/100
GradeCB−
Scorecard rank#393#36
Semaglutide$188/mo (starting dose, compounded)$199/mo
Tirzepatide$238/mo (starting dose, compounded)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
DreamHug Medical

Graded #393 · C

Strengths

  • Florida business address disclosed publicly (Pompano Beach, FL) — more transparency than many DTC competitors
  • 100% money-back guarantee if you're not approved
  • Telehealth-only with claimed all-50-state coverage via an 11,000-doctor network
  • LegitScript logo displayed

Where it loses points

  • Tirzepatide not mentioned — semaglutide-only, narrower scope than competitors
  • Pricing not disclosed — fully gated behind sign-up
  • LegitScript ID number not shown (only the logo)
  • Pharmacy partner not disclosed
  • Named medical director not disclosed
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard